Below are the financial statements of Astellas Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in trillions of JPY | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 1.6a | 1.52a | 1.3a | 1.25a |
| Gross profit | 1.31a | 1.23a | 1.04a | 1a |
| SG&A expenses | -0.74a | -0.63a | -0.55a | -0.5a |
| R&D expenses | -0.29a | -0.28a | -0.25a | -0.22a |
| Core operating profit | 0.18a | 0.29a | 0.24a | 0.25a |
| Core profit for the year | 0.15a | 0.22a | 0.19a | 0.21a |
| Operating profit | 0.03a | 0.13a | 0.16a | 0.14a |
| Profit before tax | 0.02a | 0.13a | 0.16a | 0.15a |
| Profit for the year | 0.02a | 0.1a | 0.12a | 0.12a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Astellas Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.